ASLAN PHARMACEUTICALS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.53 USD | -1.85% |
|
+5.96% | +1.51% |
Chart calendar ASLAN Pharmaceuticals Limited
6795d99d6110c529b.0GA93QsvqcjETIsCcu_p53EOfXGUGxHKm9HS7IIMJOE.mCZcsGRF4f2zG8N0AKi8kVxKHzrTKyidy-OVlcpeRpiyFWiTUXjYmrV6vw~39146b46fe7549a637e8e4985b30dc56
Upcoming events on ASLAN Pharmaceuticals Limited
Past events on ASLAN Pharmaceuticals Limited
| 2024-04-12 08:00 am | Q4 2023 Earnings Release |
| 2024-03-28 08:00 am | H.C. Wainwright Autoimmune and Inflammatory Disease Conference |
| 2024-01-09 | LifeSci Partners Corporate Access Event |
| 2024-01-07 | Biotech Showcase |
| 2024-01-06 | Dermatology Summit |
| 2023-11-29 11:30 am | Piper Sandler Healthcare Conference |
| 2023-10-30 | Dermatology Drug Development Summit |
| 2023-10-27 08:00 am | Q3 2023 Earnings Release |
| 2023-10-24 11:00 am | Investor Meeting - Key Opinion Leader |
| 2023-09-11 10:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-11 07:00 am | Q2 2023 Earnings Release |
| 2023-07-06 08:30 am | TREK-AD Phase 2b Trial Results Call |
| 2023-06-08 04:30 pm | Jefferies Global Healthcare Conference |
| 2023-05-13 12:15 am | International Societies for Investigative Dermatology Meeting - Abstract Number : LB1751 |
| 2023-05-09 | International Societies for Investigative Dermatology Meeting - Abstract Number : LB1777 |
| 2023-05-09 | International Societies for Investigative Dermatology Meeting - Abstract Number : 657 |
| 2023-05-09 | International Societies for Investigative Dermatology Meeting - Abstract Number : 1594 |
| 2023-04-28 07:00 am | Q1 2023 Earnings Release |
| 2023-03-30 10:30 am | H.C. Wainwright Autoimmune & Inflammatory Disease Conference - Fireside Chat |
| 2023-03-24 07:00 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 90,7 91,4 -0.81% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 387 379 2.21% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million TWD | Released Forecast Spread | -1 378 -674 -104.55% | -463 -402 -15.28% | -971 -889 -9.19% | -1 451 -1 404 -3.35% | -1 411 -1 321 -6.77% | -2 016 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -1 410 -682 -106.67% | -477 -427 -11.78% | -906 -850 -6.61% | -1 554 -1 506 -3.23% | -1 422 -1 347 -5.55% | -2 128 |
|
Net income Million TWD | Released Forecast Spread | -1 421 -694 -104.65% | -455 -423 -7.7% | -898 -857 -4.76% | -1 557 -1 506 -3.39% | -1 427 -1 350 -5.64% | -2 128 |
|
EPS USD | Released Forecast Spread | -7,25 -3,70 -95.95% | -2,00 -1,43 -39.54% | -2,40 -2,38 -0.7% | -3,68 -2,12 -74% | -2,69 -2,61 -3.07% | -3,62 |
| Announcement Date | 18/03/20 | 22/04/21 | 25/03/22 | 24/03/23 | 12/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 381 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million TWD | Released Forecast Spread | -319 -258 -23.66% | -349 -291 -19.94% | -369 -372 0.85% | -330 -394 16.46% | -406 -349 -16.18% | -557 -398 -39.89% | -75,2 -479 84.29% | -338 -460 26.43% | -414 -346 -19.63% | -371 | -383 | -383 | -881 | -380 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -262 -268 2.24% | -380 -310 -22.47% | -391 -403 3.07% | -349 -425 17.76% | -436 -378 -15.33% | -588 -423 -39.15% | -58,1 -527 88.97% | -314 -494 36.35% | -435 -381 -14.03% | -397 | -410 | -411 | -910 | -420 |
|
Net income Million TWD | Released Forecast Spread | -262 -277 5.41% | -380 -310 -22.47% | -391 -419 6.77% | -350 -425 17.69% | -439 -378 -15.97% | -588 -423 -39.2% | -59,9 -496 87.91% | -315 -494 36.16% | -436 -381 -14.37% | -397 | -410 | -411 | -910 | -420 |
|
EPS USD | Released Forecast Spread | -0,80 -0,72 -11.63% | -0,95 -0,90 -5.56% | -0,95 -0,60 -58.33% | -0,80 -0,95 15.79% | -1,04 -0,55 -90.83% | -1,29 -0,44 -196.55% | -0,11 -0,80 86.25% | -0,56 -0,77 27.27% | -0,79 -0,65 -21.54% | -0,61 | -0,54 | -0,53 | -1,87 | -0,56 |
| Announcement Date | 25/03/22 | 27/04/22 | 12/08/22 | 28/10/22 | 24/03/23 | 28/04/23 | 11/08/23 | 27/10/23 | 12/04/24 | - | - | - | - | - |
More events
Past sector events for ASLAN Pharmaceuticals Limited
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ASLN Stock
- Calendar ASLAN Pharmaceuticals Limited
